Atos appeals US$297.9 million TriZetto judgment in Syntel case

Atossa Therapeutics

Atossa Therapeutics

ATOS

0.00
  • Atos filed a notice of appeal on May 19, 2026, challenging an amended final judgment in the TriZetto litigation.
  • The ruling ordered Atos and its Syntel unit to pay USD 297.9 million to TriZetto, reflecting a March 27, 2026 pre-judgment decision.
  • To stay enforcement, Atos posted a USD 309 million supersedeas bond, secured by a USD 290 million cash deposit.
  • The group stated the appeal-related steps do not have a material adverse impact on assets, business, liquidity, or financial condition.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AtoS SE published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605200511OMX_____CNEWS_EN_GNW1001182998_en) on May 20, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.